Skip to main content

Leukemia

Advancements in the Management of Patients With T-Cell Lymphoma
Debates and Roundtables
01/05/2021
In the third part of this roundtable, Steven Horwitz, MD; Alison Moskowitz, MD; and Barbara Pro, MD, discuss notable advancements in the standard treatment of T-cell lymphoma.
In the third part of this roundtable, Steven Horwitz, MD; Alison Moskowitz, MD; and Barbara Pro, MD, discuss notable advancements in the standard treatment of T-cell lymphoma.
In the third part of this...
01/05/2021
Oncology
Efficacy and Safety of Current Treatment Options for HCL
Videos
01/20/2020
Jacqueline Barrientos, MD, MS, discusses how the treatment landscape for hairy cell leukemia has evolved.
Jacqueline Barrientos, MD, MS, discusses how the treatment landscape for hairy cell leukemia has evolved.
Jacqueline Barrientos, MD, MS,...
01/20/2020
Oncology
Ibrutinib Plus Rituximab Yields Significant PFS Benefit Over FCR for CLL
Videos
01/12/2020
Neil Kay, MD, discusses results from the E1912 trial, which showed a significant PFS benefit with ibrutinib plus rituximab over standard FCR in CLL.
Neil Kay, MD, discusses results from the E1912 trial, which showed a significant PFS benefit with ibrutinib plus rituximab over standard FCR in CLL.
Neil Kay, MD, discusses results...
01/12/2020
Oncology